阿尔博病毒感染和表观遗传机制;一个潜在的治疗目标
Manhong Wang1, Kexin Liu2, Dan Guo1
1University Hospital, Jilin Normal University, Siping, China.
Reviews in medical virology
|March 28, 2025
概括
关节动物传播的病毒 (arboviruses) 可以通过改变表观遗传过程来影响神经系统. 了解这些相互作用是开发神经向性树状病毒感染新疗法的关键.
科学领域:
- 神经科学是一个神经科学.
- 病毒学 病毒学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 阿尔博病毒是严重的公共卫生威胁,导致从轻度到重度的各种疾病.
- 神经热性树冠病毒特别向神经系统,可能导致神经系统疾病.
- 表观遗传机制对于正常的大脑功能至关重要,包括神经发生,可塑性,记忆和认知.
研究的目的:
- 在神经向性感染的背景下,审查 arboviruses 和表观遗传机制之间的复杂相互作用.
- 突出表观遗传放松调控在 arboviral 诱导的神经疾病中的作用.
- 探索针对病毒诱导的表观遗传变化的新型治疗策略.
主要方法:
- 文献综述侧重于研究研究 arboviral 与宿主表观遗传机制的相互作用.
- 对神经向性树状病毒感染中的表观遗传修饰 (例如,DNA甲基化,基因素修饰,非编码RNA) 的研究进行分析.
- 综合发现,阐明树状病毒神经和表观遗传调节之间的相互作用.
主要成果:
- 树冠病毒可以操纵宿主表观遗传过程,以促进其复制和致病性.
- 由 arboviruses 诱导的表观遗传变化有助于神经系统并发症的发展.
- 特定的表观遗传途径,如微RNA (miRNA) 调节,与树状病毒神经炎症和疾病严重程度有关.
结论:
- 了解 arboviruses 和宿主表观遗传学之间的相互作用对于控制神经向性 arboviral 感染至关重要.
- 针对病毒介导的表观遗传变化为开发新型抗病毒疗法提供了一个有希望的途径.
- 旨在调节表观遗传修饰的干预措施可以减轻神经炎症,并减少树状病毒神经系统疾病的疾病严重程度.
更多相关视频
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
20.8K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
相关概念视频
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21